Royal Bank Of Canada Vaxart, Inc. Transaction History
Royal Bank Of Canada
- $528 Billion
- Q2 2025
A detailed history of Royal Bank Of Canada transactions in Vaxart, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 223,866 shares of VXRT stock, worth $85,069. This represents 0.0% of its overall portfolio holdings.
Number of Shares
223,866
Previous 606
36841.58%
Holding current value
$85,069
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding VXRT
# of Institutions
106Shares Held
23.1MCall Options Held
66.1KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA10.4MShares$3.96 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$884,0200.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$674,2510.0% of portfolio
-
Marshall Wace, LLP London, X01.76MShares$670,2750.0% of portfolio
-
State Street Corp Boston, MA851KShares$323,4250.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $48.1M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...